Treatment Without ADT Delays Initiation of Systemic Therapy in Prostate Cancer
MONDAY, Nov. 21, 2022 -- For prostate cancer patients with a solitary oligometastatic lesion, metastasis-directed therapy without androgen deprivation therapy (ADT) can delay initiation of systemic therapy, according to a study published in the...
Read more »